Drug companies could have made naloxone more accessible. Why didn’t they? https://www.washingtonpost.com/opinions/2023/01/23/naloxone-over-the-counter-opioid-overdose-antidote/#new_tab
FDA Fast-Tracks Review of Overdose Drug Naloxone for Use Without Prescription by Philip Kantor | Jan 3, 2023 | News
New Drug Application for RiVive™ Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA by Philip Kantor | Jan 3, 2023 | News
